Report Detail

Pharma & Healthcare Global Pharma-Grade Hyaluronic Acid Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4349069
  • |
  • 10 February, 2023
  • |
  • Global
  • |
  • 96 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Pharma-Grade Hyaluronic Acid market size was valued at USD 167.5 million in 2022 and is forecast to a readjusted size of USD 324.2 million by 2029 with a CAGR of 9.9% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key players of pharma-grade hyaluronic acid include Bloomage Biotech, HTL Biotechnology, Kewpie, Contipro, Fidia Farmaceutici, etc. The top five players hold a share about 78%. Europe is the largest market, has a share about 51%, followed by North America and Asia-Pacific , with share 26% and 21%, separately.
Hyaluronic acid is a naturally occurring substance that helps retain moisture in the skin and eyes and lubricates the joints. Pharma-Grade Hyaluronic Acid is generally used in pharmaceutical formulations, such as Injection Product and Eye Drops for osteoarthritis of the knee joint. Hyaluronic acid also called hyaluronan, is an anionic, nonsulfated glycosaminoglycan distributed widely throughout connective, epithelial, and neural tissues. It is unique among glycosaminoglycans in that it is nonsulfated, forms in the plasma membrane instead of the Golgi apparatus, and can be very large: human synovial HA averages about 7 million Da per molecule, or about 20000 disaccharide monomers, while other sources mention 3–4 million Da. As one of the chief components of the extracellular matrix, hyaluronan contributes significantly to cell proliferation and migration, and may also be involved in the progression of some malignant tumors.
This report is a detailed and comprehensive analysis for global Pharma-Grade Hyaluronic Acid market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Pharma-Grade Hyaluronic Acid market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2018-2029
Global Pharma-Grade Hyaluronic Acid market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2018-2029
Global Pharma-Grade Hyaluronic Acid market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2018-2029
Global Pharma-Grade Hyaluronic Acid market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (US$/Kg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharma-Grade Hyaluronic Acid
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharma-Grade Hyaluronic Acid market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bloomage Biotech, AWA Biopharm, Kewpie, Contipro and Seikagaku, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Pharma-Grade Hyaluronic Acid market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Microbial Fermentation
Animal Tissue
Market segment by Application
Injection Product
Eye Drops
Major players covered
Bloomage Biotech
AWA Biopharm
Kewpie
Contipro
Seikagaku
HTL Biotechnology
Fidia Farmaceutici
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pharma-Grade Hyaluronic Acid product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pharma-Grade Hyaluronic Acid, with price, sales, revenue and global market share of Pharma-Grade Hyaluronic Acid from 2018 to 2023.
Chapter 3, the Pharma-Grade Hyaluronic Acid competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pharma-Grade Hyaluronic Acid breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Pharma-Grade Hyaluronic Acid market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pharma-Grade Hyaluronic Acid.
Chapter 14 and 15, to describe Pharma-Grade Hyaluronic Acid sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Pharma-Grade Hyaluronic Acid
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Pharma-Grade Hyaluronic Acid Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Microbial Fermentation
    • 1.3.3 Animal Tissue
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Pharma-Grade Hyaluronic Acid Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Injection Product
    • 1.4.3 Eye Drops
  • 1.5 Global Pharma-Grade Hyaluronic Acid Market Size & Forecast
    • 1.5.1 Global Pharma-Grade Hyaluronic Acid Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Pharma-Grade Hyaluronic Acid Sales Quantity (2018-2029)
    • 1.5.3 Global Pharma-Grade Hyaluronic Acid Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Bloomage Biotech
    • 2.1.1 Bloomage Biotech Details
    • 2.1.2 Bloomage Biotech Major Business
    • 2.1.3 Bloomage Biotech Pharma-Grade Hyaluronic Acid Product and Services
    • 2.1.4 Bloomage Biotech Pharma-Grade Hyaluronic Acid Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Bloomage Biotech Recent Developments/Updates
  • 2.2 AWA Biopharm
    • 2.2.1 AWA Biopharm Details
    • 2.2.2 AWA Biopharm Major Business
    • 2.2.3 AWA Biopharm Pharma-Grade Hyaluronic Acid Product and Services
    • 2.2.4 AWA Biopharm Pharma-Grade Hyaluronic Acid Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 AWA Biopharm Recent Developments/Updates
  • 2.3 Kewpie
    • 2.3.1 Kewpie Details
    • 2.3.2 Kewpie Major Business
    • 2.3.3 Kewpie Pharma-Grade Hyaluronic Acid Product and Services
    • 2.3.4 Kewpie Pharma-Grade Hyaluronic Acid Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Kewpie Recent Developments/Updates
  • 2.4 Contipro
    • 2.4.1 Contipro Details
    • 2.4.2 Contipro Major Business
    • 2.4.3 Contipro Pharma-Grade Hyaluronic Acid Product and Services
    • 2.4.4 Contipro Pharma-Grade Hyaluronic Acid Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Contipro Recent Developments/Updates
  • 2.5 Seikagaku
    • 2.5.1 Seikagaku Details
    • 2.5.2 Seikagaku Major Business
    • 2.5.3 Seikagaku Pharma-Grade Hyaluronic Acid Product and Services
    • 2.5.4 Seikagaku Pharma-Grade Hyaluronic Acid Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Seikagaku Recent Developments/Updates
  • 2.6 HTL Biotechnology
    • 2.6.1 HTL Biotechnology Details
    • 2.6.2 HTL Biotechnology Major Business
    • 2.6.3 HTL Biotechnology Pharma-Grade Hyaluronic Acid Product and Services
    • 2.6.4 HTL Biotechnology Pharma-Grade Hyaluronic Acid Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 HTL Biotechnology Recent Developments/Updates
  • 2.7 Fidia Farmaceutici
    • 2.7.1 Fidia Farmaceutici Details
    • 2.7.2 Fidia Farmaceutici Major Business
    • 2.7.3 Fidia Farmaceutici Pharma-Grade Hyaluronic Acid Product and Services
    • 2.7.4 Fidia Farmaceutici Pharma-Grade Hyaluronic Acid Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Fidia Farmaceutici Recent Developments/Updates

3 Competitive Environment: Pharma-Grade Hyaluronic Acid by Manufacturer

  • 3.1 Global Pharma-Grade Hyaluronic Acid Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Pharma-Grade Hyaluronic Acid Revenue by Manufacturer (2018-2023)
  • 3.3 Global Pharma-Grade Hyaluronic Acid Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Pharma-Grade Hyaluronic Acid by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Pharma-Grade Hyaluronic Acid Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Pharma-Grade Hyaluronic Acid Manufacturer Market Share in 2022
  • 3.5 Pharma-Grade Hyaluronic Acid Market: Overall Company Footprint Analysis
    • 3.5.1 Pharma-Grade Hyaluronic Acid Market: Region Footprint
    • 3.5.2 Pharma-Grade Hyaluronic Acid Market: Company Product Type Footprint
    • 3.5.3 Pharma-Grade Hyaluronic Acid Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Pharma-Grade Hyaluronic Acid Market Size by Region
    • 4.1.1 Global Pharma-Grade Hyaluronic Acid Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Pharma-Grade Hyaluronic Acid Consumption Value by Region (2018-2029)
    • 4.1.3 Global Pharma-Grade Hyaluronic Acid Average Price by Region (2018-2029)
  • 4.2 North America Pharma-Grade Hyaluronic Acid Consumption Value (2018-2029)
  • 4.3 Europe Pharma-Grade Hyaluronic Acid Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Pharma-Grade Hyaluronic Acid Consumption Value (2018-2029)
  • 4.5 South America Pharma-Grade Hyaluronic Acid Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Pharma-Grade Hyaluronic Acid Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Pharma-Grade Hyaluronic Acid Sales Quantity by Type (2018-2029)
  • 5.2 Global Pharma-Grade Hyaluronic Acid Consumption Value by Type (2018-2029)
  • 5.3 Global Pharma-Grade Hyaluronic Acid Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Pharma-Grade Hyaluronic Acid Sales Quantity by Application (2018-2029)
  • 6.2 Global Pharma-Grade Hyaluronic Acid Consumption Value by Application (2018-2029)
  • 6.3 Global Pharma-Grade Hyaluronic Acid Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Pharma-Grade Hyaluronic Acid Sales Quantity by Type (2018-2029)
  • 7.2 North America Pharma-Grade Hyaluronic Acid Sales Quantity by Application (2018-2029)
  • 7.3 North America Pharma-Grade Hyaluronic Acid Market Size by Country
    • 7.3.1 North America Pharma-Grade Hyaluronic Acid Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Pharma-Grade Hyaluronic Acid Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Pharma-Grade Hyaluronic Acid Sales Quantity by Type (2018-2029)
  • 8.2 Europe Pharma-Grade Hyaluronic Acid Sales Quantity by Application (2018-2029)
  • 8.3 Europe Pharma-Grade Hyaluronic Acid Market Size by Country
    • 8.3.1 Europe Pharma-Grade Hyaluronic Acid Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Pharma-Grade Hyaluronic Acid Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Pharma-Grade Hyaluronic Acid Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Pharma-Grade Hyaluronic Acid Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Pharma-Grade Hyaluronic Acid Market Size by Region
    • 9.3.1 Asia-Pacific Pharma-Grade Hyaluronic Acid Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Pharma-Grade Hyaluronic Acid Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Pharma-Grade Hyaluronic Acid Sales Quantity by Type (2018-2029)
  • 10.2 South America Pharma-Grade Hyaluronic Acid Sales Quantity by Application (2018-2029)
  • 10.3 South America Pharma-Grade Hyaluronic Acid Market Size by Country
    • 10.3.1 South America Pharma-Grade Hyaluronic Acid Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Pharma-Grade Hyaluronic Acid Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Pharma-Grade Hyaluronic Acid Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Pharma-Grade Hyaluronic Acid Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Pharma-Grade Hyaluronic Acid Market Size by Country
    • 11.3.1 Middle East & Africa Pharma-Grade Hyaluronic Acid Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Pharma-Grade Hyaluronic Acid Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Pharma-Grade Hyaluronic Acid Market Drivers
  • 12.2 Pharma-Grade Hyaluronic Acid Market Restraints
  • 12.3 Pharma-Grade Hyaluronic Acid Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Pharma-Grade Hyaluronic Acid and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Pharma-Grade Hyaluronic Acid
  • 13.3 Pharma-Grade Hyaluronic Acid Production Process
  • 13.4 Pharma-Grade Hyaluronic Acid Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Pharma-Grade Hyaluronic Acid Typical Distributors
  • 14.3 Pharma-Grade Hyaluronic Acid Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Pharma-Grade Hyaluronic Acid. Industry analysis & Market Report on Pharma-Grade Hyaluronic Acid is a syndicated market report, published as Global Pharma-Grade Hyaluronic Acid Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Pharma-Grade Hyaluronic Acid market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,784.00
    4,176.00
    5,568.00
    3,250.32
    4,875.48
    6,500.64
    547,508.40
    821,262.60
    1,095,016.80
    290,197.20
    435,295.80
    580,394.40
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report